看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
3 `+ f# [3 ^3 X! d# `/ O' |& F
. Q9 K8 G+ S, v! n
8 ]9 d I1 F4 n' l8 x0 J" QCurrently available feasibility data for possible combination strategies.
: {' t2 O: l' X3 K, |. z' A————————————————————————————————
3 M. ^: t0 L5 T- O2 uCombination Feasibility according to preliminary data + g1 {. X( ]4 h
——————————————————————————————————
( t( v; _1 m. `- C/ X7 fBevacizumab + sorafenib Yes, reduced dose
8 D, [: z9 ~3 t$ L" v' H! h/ tBevacizumab + sunitinib† No
7 @. o& w/ z4 [) f8 W: k' c5 CBevacizumab + temsirolimus Yes ) _6 p9 G6 S4 b e, M9 H6 h+ S
Bevacizumab + everolimus Yes $ C; ]6 i a$ Y! z) \2 ~1 l
Sorafenib + sunitinib ?
3 v/ B- C- W* a3 g9 G, cSorafenib + temsirolimus Yes, reduced dose
L9 _- ^( @; \' h4 b! DSorafenib + everolimus Yes, reduced dose " d y! }* V+ u" c3 G( Z
Sunitinib + temsirolimus† No
6 ]8 U) g3 e% z; I" ^Sunitinib + everolimus ?
7 }$ H* r0 S( V7 g* B: `, STemsirolimus + everolimus ? 5 D3 K$ _6 s0 |! L9 X
————————————————————4 @# K& x! z+ g/ m6 F
†Led to US FDA warning.
5 K4 }' Y9 l$ \- P3 z?: As yet unattempted combination.
" ]: y/ \; g/ w! F5 o) b |